Last reviewed · How we verify
Platelet-rich Plasma Local injection
At a glance
| Generic name | Platelet-rich Plasma Local injection |
|---|---|
| Sponsor | Biobizkaia Health Research Institute |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases (PHASE1, PHASE2)
- Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia (PHASE3)
- Low-Cost Platelet-Rich Plasma for Hemarthropathy (NA)
- Comparison Between Transarterial Musculoskeletal Embolization and Platelet-Rich Plasma Injection for the Treatment of Greater Trochanteric Pain Syndrome (PHASE2)
- Comparison Between Two Techniques in Treatment of Female Stress Urinary Incontinence (PHASE3)
- Vocal Fold Injection by Platelet Rich Plasma (NA)
- Platelet Rich Plasma Testis Treatment for Infertile Men (NA)
- Regenerative Treatment of Female Genital Atrophy (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: